Blood-Filtering Treatment for Severe Thermal Burns
Part of Injuries & trauma clinical trials.
This trial tests a special blood-filtering machine called Efferon LPS that removes harmful substances from the blood of patients with severe thermal burns. The goal is to help patients recover better by reducing the body's inflammatory response to the burn injury.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a thermal burn (from flame, hot liquid, or contact) that may include smoke inhalation injury
- Your burn severity score falls within a specific range (RFI score between 71 and 181)
- Your doctor recommends blood filtration therapy and can start it within 10 days of your burn injury
- You are stable enough to receive at least 6 hours of continuous Efferon LPS treatment
- You do not have other major injuries (like broken bones, head trauma, or heart attack) or serious infections
- Your heart and lungs can tolerate the procedure without emergency surgery needed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a blood-filtering device (Efferon LPS NEO) that removes harmful substances from the blood of children with severe thermal burns. It may help reduce complications and improve recovery.
This trial tests a special blood filter called Efferon LPS that removes harmful substances from the blood of people with severe burns. It aims to help the body recover by reducing inflammation and infection.
This trial tests a special blood filter (hemoadsorption) for people in septic shock (a severe infection causing very low blood pressure). It aims to see if the filter helps remove harmful substances from the blood and improve recovery.
This trial tests whether using blood “filters” plus high-volume fluid filtration can improve outcomes in adults with acute pancreatitis without infection. It aims to remove inflammatory substances from the blood early, while ensuring you’re stable enough for several hours of treatment.
This trial tests a special blood-filtering device (Efferon LPS) used during heart surgery to reduce inflammation and improve recovery. The device removes harmful substances from your blood during the operation.
This trial tests whether a special blood filter (Efferon LPS) can help people with moderate to severe acute pancreatitis by removing harmful substances. It is for those who have been sick for 5 days or less and have certain signs of inflammation or organ stress.
Hear when a new Burns trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.